{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:35:21Z","timestamp":1790523321587,"version":"4.1.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1003","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Sarcoidosis is a multi-system disorder characterised by non-caseating granulomas. Coexistence of sarcoidosis with immune-mediated and chronic inflammatory diseases has been described in case series. However, the coexistence of two different diseases in individuals can occur by chance, even if each of the diseases is rare.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To determine whether sarcoidosis necessitating hospital admission or day-case care coexists with a range of immune-mediated and chronic inflammatory diseases more commonly than expected by chance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Analysis of an epidemiological database of hospital admission and day-case statistics, spanning 30 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>1510 patients with sarcoidosis were identified (mean age 44 years, median follow-up 19 years) who had been admitted to hospital or day-case care. Significant associations in the sarcoidosis cohort were identified with systemic lupus erythematosus (odds ratio (OR) 8.3; 95% CI 2.7 to 19.4), autoimmune chronic hepatitis (OR 6.7; 95% CI 1.8 to 17.1), multiple sclerosis (OR 3.3; 95% CI 1.7 to 5.6), coeliac disease (OR 3.1; 95% CI 1.01 to 7.3), thyrotoxicosis (OR 2.5; 95% CI 1.4 to 4.0), myxoedema (OR 2.2; 95% CI 1.2 to 3.7) and ulcerative colitis (OR 2.1; 95% CI 1.1 to 3.7). Weaker associations were found for diabetes mellitus with a first admission aged 30\u201349 years (OR 2.9; 95% CI 2.1 to 4.0) or age &amp;gt;50 (OR 1.7; 95% CI 1.2 to 2.3), but not for people age &amp;lt;30. No significant association with Crohn\u2019s disease (OR 1.52; 95% CI 0.61 to 3.14) or primary biliary cirrhosis (OR 3.75; 95% CI 0.77 to 11.0),was found. When all immune-mediated and chronic inflammatory diseases for which associations were sought were combined, the overall rate ratio associated with sarcoidosis was 2.2 (95% CI 1.9 to 2.6).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study adds epidemiological evidence to information from clinical reports that there is a connection between sarcoidosis and other immune-mediated and chronic inflammatory diseases.<\/jats:p><\/jats:sec>","DOI":"10.1136\/pgmj.2008.067769","type":"journal-article","created":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T17:43:37Z","timestamp":1244742217000},"page":"233-237","source":"Crossref","is-referenced-by-count":59,"title":["Immune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database"],"prefix":"10.1093","volume":"85","author":[{"given":"N","family":"Rajoriya","sequence":"first","affiliation":[{"name":"Gastroenterology Unit, John Radcliffe Hospital , Oxford , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J","family":"Wotton","sequence":"additional","affiliation":[{"name":"Unit of Health-Care Epidemiology, Department of Public Health, Oxford University , Oxford , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D G R","family":"Yeates","sequence":"additional","affiliation":[{"name":"Unit of Health-Care Epidemiology, Department of Public Health, Oxford University , Oxford , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S P L","family":"Travis","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, John Radcliffe Hospital , Oxford , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Goldacre","sequence":"additional","affiliation":[{"name":"Unit of Health-Care Epidemiology, Department of Public Health, Oxford University , Oxford , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,6,11]]},"reference":[{"key":"2023041909285337000_b1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-2007-970331","article-title":"Epidemiology of sarcoidosis: recent advances and future prospects","volume":"28","author":"Rybicki","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"2023041909285337000_b2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0041-3879(69)90048-8","article-title":"Geographic variations in the incidence of sarcoidosis in Great Britain: a comparative study of four areas","volume":"50","author":"Baldry","year":"1969","journal-title":"Tubercle"},{"key":"2023041909285337000_b3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ccm.2008.03.013","article-title":"Sarcoidosis around the world","volume":"29","author":"Sharma","year":"2008","journal-title":"Clin Chest Med"},{"key":"2023041909285337000_b4","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/world Association of Sarcoidosis and other Granulomatous diseases","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lug Dis"},{"key":"2023041909285337000_b5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1513\/pats.200607-138MS","article-title":"Lessons learned from ACCESS (A Case Controlled Etiologic Study of Sarcoidosis)","volume":"4","author":"Rossman","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"2023041909285337000_b6","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N Engl J Med"},{"key":"2023041909285337000_b7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1399-0004.2008.00970.x","article-title":"Advances in the genetics of sarcoidosis","volume":"73","author":"Smith","year":"2008","journal-title":"Clin Genet"},{"key":"2023041909285337000_b8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccm.2008.03.014","article-title":"The immunology of sarcoidosis","volume":"29","author":"Gerke","year":"2008","journal-title":"Clin Chest Med"},{"key":"2023041909285337000_b9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/qjmed\/hcg103","article-title":"Endocrine and reproductive manifestations of sarcoidosis","volume":"96","author":"Porter","year":"2003","journal-title":"QJM"},{"key":"2023041909285337000_b10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00063198-200209000-00019","article-title":"Sarcoidosis and other autoimmune disorders","volume":"8","author":"Sharma","year":"2002","journal-title":"Curr Opin Pulm Med"},{"key":"2023041909285337000_b11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/qjmed\/93.10.669","article-title":"Use of large medical databases to study associations between diseases","volume":"93","author":"Goldacre","year":"2000","journal-title":"QJM"},{"key":"2023041909285337000_b12","first-page":"1","article-title":"Statistical methods in cancer research. Volume II. The design and analysis of cohort studies","volume":"82","author":"Breslow","year":"1987","journal-title":"IARC Sci Publ"},{"key":"2023041909285337000_b13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1378\/chest.130.2.526","article-title":"Prevalence of hypothyroidism and Graves disease in sarcoidosis","volume":"130","author":"Antonelli","year":"2006","journal-title":"Chest"},{"key":"2023041909285337000_b14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/eje.0.1340331","article-title":"High frequency of endocrine autoimmunity in patients with sarcoidosis","volume":"134","author":"Papadopoulos","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"2023041909285337000_b15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2265.1997.1630976.x","article-title":"High incidence of positive antibodies against thyroid peroxidase and thyroglobulin in patients with sarcoidosis","volume":"46","author":"Nakamura","year":"1997","journal-title":"Clinical Endocrinol"},{"key":"2023041909285337000_b16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00042737-200409000-00016","article-title":"Prevalence of coeliac disease in patients with sarcoidosis","volume":"16","author":"Rutherford","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2023041909285337000_b17","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1136\/gut.29.12.1628","article-title":"Altered gastrointestinal immune responses in sarcoidosis","volume":"29","author":"McCormick","year":"1988","journal-title":"Gut"},{"key":"2023041909285337000_b18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10620-007-9974-2","article-title":"Sarcoidosis in patients with celiac disease","volume":"53","author":"Hwang","year":"2008","journal-title":"Dig Dis Sci"},{"key":"2023041909285337000_b19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s10350-007-9165-4","article-title":"Ulcerative colitis accompanied with sarcoidosis and dermatomyositis: report of a case","volume":"51","author":"Hayashi","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"2023041909285337000_b20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1742-1241.1994.tb09834.x","article-title":"Crohn\u2019s and sarcoidosis: different manifestations of the same disease process?","volume":"48","author":"Kiely","year":"1994","journal-title":"Br J Clin Pract"},{"key":"2023041909285337000_b21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s004080000104","article-title":"Sarcoidosis: impact of other illnesses on the presentation and management of multi-organ disease","volume":"180","author":"Reynolds","year":"2002","journal-title":"Lung"},{"key":"2023041909285337000_b22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur Respir J"},{"key":"2023041909285337000_b23","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","article-title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","volume":"14","author":"Miller","year":"2008","journal-title":"Mult Scler"},{"key":"2023041909285337000_b24","first-page":"149","article-title":"Primary biliary cirrhosis associated with sarcoidosis and myasthenia","volume":"140","author":"Turner","year":"1989","journal-title":"Ann Med Interne (Paris)"},{"key":"2023041909285337000_b25","first-page":"549","article-title":"Concurrence of sarcoidosis and systemic lupus erythematosus in three patients","volume":"20","author":"Begum","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"2023041909285337000_b26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1262-3636(07)70012-5","article-title":"Post-partum recurrent sarcoidosis associated with type 1 diabetes mellitus","volume":"29","author":"Djrolo","year":"2003","journal-title":"Diabetes Metab"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/85\/1003\/233\/50020195\/postgradmedj-85-233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/85\/1003\/233\/50020195\/postgradmedj-85-233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T17:07:33Z","timestamp":1685034453000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/85\/1003\/233\/7007402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,1]]},"references-count":26,"journal-issue":{"issue":"1003","published-online":{"date-parts":[[2009,6,11]]},"published-print":{"date-parts":[[2009,5,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2008.067769","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009,5]]},"published":{"date-parts":[[2009,5,1]]}}}